Empresa Ceapro Inc Toronto S.E.
Acciones
CZO
CA1499071076
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 01/01/07 |
Director of Finance/CFO | - | 05/05/15 | |
Mitch Regnier
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/23 |
Paul Moquin
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/18 |
Chief Tech/Sci/R&D Officer | - | 01/01/10 | |
General Counsel | - | - | |
Leoni DeJoya
PRN | Corporate Officer/Principal | - | 07/01/19 |
52 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 01/01/07 |
Ulrich Kosciessa
BRD | Director/Board Member | - | 27/04/15 |
William Li
BRD | Director/Board Member | 61 | 20/11/14 |
Ronald Miller
CHM | Chairman | - | 02/03/22 |
Geneviève Foster
BRD | Director/Board Member | - | 19/04/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 78 293 177 | 76 755 900 ( 98,04 %) | 0 | 98,04 % |
Información de la empresa
![Dirección Ceapro Inc(CZO)](https://cdn.zonebourse.com/static/address/1409692.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+22,15 % | 46,55 mil M | |
+45,94 % | 41,84 mil M | |
-2,37 % | 40,84 mil M | |
+33,84 % | 32,95 mil M | |
-6,35 % | 28,27 mil M | |
+20,42 % | 27,78 mil M | |
+48,83 % | 14,26 mil M | |
+45,00 % | 13,69 mil M | |
+0,06 % | 12,18 mil M |